title: Cutaneous Gamma-Delta T-Cell Lymphoma Successfully Treated With Brentuximab Vedotin.
authors.affiliation: Department of Pathology, City of Hope, Duarte, California.
authors.forename: Belen
authors.initials: B
authors.lastname: Rubio-Gonzalez
authors.affiliation: Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
authors.forename: Jasmine
authors.initials: J
authors.lastname: Zain
authors.affiliation: Division of Cytogenetics, City of Hope, Duarte, California.
authors.forename: Lino
authors.initials: L
authors.lastname: Garcia
authors.affiliation: Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
authors.forename: Steven T
authors.initials: ST
authors.lastname: Rosen
authors.affiliation: Department of Pathology, City of Hope, Duarte, California2Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California4Department of Surgery, Division of Dermatology, City of Hope, Duarte, California.
authors.forename: Christiane
authors.initials: C
authors.lastname: Querfeld
mesh_terms: D000328:Adult; D001706:Biopsy; D000079963:Brentuximab Vedotin; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D012867:Skin / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin